|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2010 USD | -.--% |
|
-.--% | +66.12% |
| Market Cap | 1.55M 1.35M 1.25M 1.15M 2.19M 148M 2.23M 14.94M 5.86M 72.5M 5.81M 5.68M 251M | P/E 2023 |
-25x | P/E 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 931K 859K 795K 1.51M 102M 1.53M 10.29M 4.03M 49.9M 4M 3.91M 173M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 3 months | -28.21% | ||
| 6 months | +66.12% | ||
| Current year | +66.12% |
| Current year | 0.12 | 0.28 | |
| 1 year | 0.1 | 0.28 | |
| 3 years | 0 | 0.34 | |
| 5 years | 0 | 0.64 | |
| 10 years | 0 | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 09/01/2018 |
James Anderson
CEO | Chief Executive Officer | 56 | 22/09/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 01/01/2006 |
James Anderson
BRD | Director/Board Member | 56 | 01/12/2006 |
Regina Anderson
CHM | Chairman | 79 | 01/09/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/07/24 | Other | Director | 7,440 | 0.0918% | ||
| 31/07/24 | Other | Director | 7,200 | 0.0888% | ||
| 31/07/24 | Other | Director | 5,600 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | +5.79% | -18.95% | 1.65M | ||
| +0.09% | +0.25% | +54.65% | +169.19% | 1,084B | ||
| -1.63% | -1.50% | +65.79% | +62.70% | 634B | ||
| -1.12% | -4.27% | +31.10% | +84.44% | 447B | ||
| +0.18% | -1.76% | +29.04% | +26.51% | 330B | ||
| -6.22% | -8.14% | +28.87% | +32.09% | 295B | ||
| -1.27% | -2.91% | +27.42% | +46.39% | 285B | ||
| -0.93% | -3.57% | -27.74% | -40.38% | 218B | ||
| -1.19% | -2.81% | +22.63% | +66.30% | 199B | ||
| -0.72% | +2.72% | +19.07% | +81.19% | 169B | ||
| Average | -1.15% | -1.14% | +25.66% | +50.95% | 365.99B | |
| Weighted average by Cap. | -0.90% | -1.18% | +38.91% | +84.80% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.1M 3.78M 3.5M 6.64M 447M 6.75M 45.28M 17.75M 220M 17.59M 17.21M 761M | 4.98M 4.36M 4.02M 3.72M 7.06M 476M 7.18M 48.15M 18.88M 234M 18.71M 18.31M 809M |
| Net income | -50.24K -43.95K -40.53K -37.5K -71.18K -4.8M -72.37K -485K -190K -2.36M -189K -185K -8.16M | -341K -298K -275K -255K -483K -32.56M -491K -3.3M -1.29M -15.99M -1.28M -1.25M -55.39M |
| Net Debt | -427K -374K -345K -319K -606K -40.8M -616K -4.13M -1.62M -20.04M -1.6M -1.57M -69.41M | -482K -422K -389K -360K -683K -46.02M -694K -4.66M -1.83M -22.6M -1.81M -1.77M -78.28M |
Employees
20
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PCYN Stock
Select your edition
All financial news and data tailored to specific country editions
















